Subsequent treatment strategies following rituximab-resistance in AQP4-IgG+ neuromyelitis optica spectrum disorder: a case series.

Deng M, Chen L, Chen W, Zeng K, Yao Y, Chen H, Lin A

Front Immunol. 2026; 17:1762535. PMID: 42079607. Abstract